| Original language | English |
|---|---|
| Pages (from-to) | 3814-3817 |
| Number of pages | 4 |
| Journal | Allergy |
| Volume | 76 |
| Issue number | 12 |
| Early online date | 4 Sept 2021 |
| DOIs |
|
| Publication status | Published - Dec 2021 |
Access to Document
- 10.1111/all.15064Licence: CC BY-NC
- Allergy - 2021 - Bakker - Conjunctival inflammation in dupilumab‐treated atopic dermatitis comprises a multicellularFinal published version, 2.17 MBLicence: CC BY-NC
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Allergy, Vol. 76, No. 12, 12.2021, p. 3814-3817.
Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review
TY - JOUR
T1 - Conjunctival inflammation in dupilumab-treated atopic dermatitis comprises a multicellular infiltrate with elevated T1/T17 cytokines
T2 - A case series study
AU - Bakker, Daphne S.
AU - ter Linde, José J.M.
AU - Amini, Mojtaba M.
AU - Ariëns, Lieneke F.M.
AU - van Luijk, Chantal M.
AU - de Bruin-Weller, Marjolein S.
AU - Thijs, Judith L.
AU - Vercoulen, Yvonne
AU - van Wijk, Femke
N1 - Funding Information: D.S. Bakker reports personal fees from Sanofi/Regeneron, personal fees from Leo Pharma, outside the submitted work. C.M. van Luijk reports personal fees from Sanofi Europe and Santen Europe, outside the submitted work. Dr. de Bruin‐Weller reports grants and other from Sanofi‐Genzyme, grants and other from Regeneron, grants and other from AbbVie, other from Arena, other from Almirall, grants and other from Eli‐Lilly, other from Galderma, other from Janssen, grants and other from Leo Pharma, other from Pfizer, outside the submitted work. Dr. Thijs reports personal fees from Sanofi/Regeneron and Leo Pharma, outside the submitted work. Dr. Vercoulen reports grants from NWO Gravitation 024.001.028 cancergenomicscenter.nl, during the conduct of the study; grants from WKZ fund research grant, grants from TKI‐Health Holland grant, grants and non‐financial support from TigaTx B.V., grants from Vrienden van het UMC Utrecht, non‐financial support from Life Science editors parental leave grant, outside the submitted work. Dr. van Wijk reports grants from Investigator initiated studies Regeneron and Leo Pharma, outside the submitted work. All other authors have nothing to disclose.
PY - 2021/12
Y1 - 2021/12
UR - http://www.scopus.com/inward/record.url?scp=85114186911&partnerID=8YFLogxK
U2 - 10.1111/all.15064
DO - 10.1111/all.15064
M3 - Comment/Letter to the editor
C2 - 34449906
SN - 0105-4538
VL - 76
SP - 3814
EP - 3817
JO - Allergy
JF - Allergy
IS - 12
ER -